InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Fitzpatrick Jennifer. Director active across 1 company, notably Sionna Therapeutics, Inc.. Cumulatively, 5 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €391k. Activity tracked since 4 September 2025. The latest transaction was filed on 6 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations
Jennifer Fitzpatrick has filed 5 transactions in total. In the 5 recent filings we hold, they relate to Sionna Therapeutics, Inc., listed on XNAS, with 0 EUR of buys and 390692 EUR of sells between 2025-09-05 and 2026-07-07. The role listed for the company is Chief Legal Officer.